209 related articles for article (PubMed ID: 33821666)
21. [Sacral neuromodulation for refractory overactive bladder].
van Ophoven A
Urologe A; 2018 Nov; 57(11):1375-1388. PubMed ID: 30310935
[TBL] [Abstract][Full Text] [Related]
22. Role of sacral neuromodulation in modern urogynaecology practice: a review of recent literature.
Tahseen S
Int Urogynecol J; 2018 Aug; 29(8):1081-1091. PubMed ID: 29302716
[TBL] [Abstract][Full Text] [Related]
23. Sacral neuromodulation: Rechargeable versus non-rechargeable device. What would the patient preferences be in France?
Gamé X; Ruffion A; Cornu JN; Phé V; Peyronnet B; Perrouin-Verbe MA; Aublant C; Adé A; Chartier-Kastler E
Prog Urol; 2022 Sep; 32(10):672-680. PubMed ID: 35752523
[TBL] [Abstract][Full Text] [Related]
24. Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects.
Tilborghs S; De Wachter S
Expert Rev Med Devices; 2022 Feb; 19(2):161-187. PubMed ID: 35061951
[TBL] [Abstract][Full Text] [Related]
25. Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder.
Noblett K; Siegel S; Mangel J; Griebling TL; Sutherland SE; Bird ET; Comiter C; Culkin D; Bennett J; Zylstra S; Kan F; Berg KC
Neurourol Urodyn; 2016 Feb; 35(2):246-51. PubMed ID: 25546568
[TBL] [Abstract][Full Text] [Related]
26. An overview of sacral neuromodulation: a treatment for patients with symptoms of lower urinary tract dysfunction.
Fletcher N
Br J Nurs; 2020 Aug; 29(15):848-856. PubMed ID: 32790556
[TBL] [Abstract][Full Text] [Related]
27. Overactive Bladder.
White N; Iglesia CB
Obstet Gynecol Clin North Am; 2016 Mar; 43(1):59-68. PubMed ID: 26880508
[TBL] [Abstract][Full Text] [Related]
28. Specific Changes in Brain Activity during Urgency in Women with Overactive Bladder after Successful Sacral Neuromodulation: A Functional Magnetic Resonance Imaging Study.
Weissbart SJ; Bhavsar R; Rao H; Wein AJ; Detre JA; Arya LA; Smith AL
J Urol; 2018 Aug; 200(2):382-388. PubMed ID: 29630979
[TBL] [Abstract][Full Text] [Related]
29. Update on sacral neuromodulation and overactive bladder in pediatrics: A systematic review.
Casal Beloy I; García-Novoa MA; García González M; Somoza Argibay I
Arch Esp Urol; 2021 Sep; 74(7):699-708. PubMed ID: 34472439
[TBL] [Abstract][Full Text] [Related]
30. What uro-gynecologists should know about sacral neuromodulation (SNM) for the treatment of refractory overactive bladder.
Oelke M; Addali M; Reisenauer C
Arch Gynecol Obstet; 2019 May; 299(5):1243-1252. PubMed ID: 30941558
[TBL] [Abstract][Full Text] [Related]
31. Refractory overactive bladder after urethrolysis for bladder outlet obstruction: management with sacral neuromodulation.
Starkman JS; Duffy JW; Wolter CE; Kaufman MR; Scarpero HM; Dmochowski RR
Int Urogynecol J Pelvic Floor Dysfunct; 2008 Feb; 19(2):277-82. PubMed ID: 17671752
[TBL] [Abstract][Full Text] [Related]
32. Sacral neuromodulation for treating the symptoms of overactive bladder syndrome and non-obstructive urinary retention: >10 years of clinical experience.
Chartier-Kastler E
BJU Int; 2008 Feb; 101(4):417-23. PubMed ID: 18070181
[No Abstract] [Full Text] [Related]
33. Sacral neuromodulation for refractory overactive bladder after prior intravesical onabotulinumtoxinA treatment.
Hoag N; Plagakis S; Pillay S; Edwards AW; Gani J
Neurourol Urodyn; 2017 Jun; 36(5):1377-1381. PubMed ID: 27612039
[TBL] [Abstract][Full Text] [Related]
34. Outcomes in a contemporary cohort undergoing sacral neuromodulation using optimized lead placement technique.
Adelstein SA; Lee W; Gioia K; Moskowitz D; Stamnes K; Lucioni A; Kobashi KC; Lee UJ
Neurourol Urodyn; 2019 Aug; 38(6):1595-1601. PubMed ID: 31044466
[TBL] [Abstract][Full Text] [Related]
35. The role of electrical stimulation techniques in the management of the male patient with urgency incontinence.
Johnsen NV; Osborn DJ; Dmochowski RR
Curr Opin Urol; 2014 Nov; 24(6):560-5. PubMed ID: 25144143
[TBL] [Abstract][Full Text] [Related]
36. One-year outcomes of the ARTISAN-SNM study with the Axonics System for the treatment of urinary urgency incontinence.
Benson K; McCrery R; Taylor C; Padron O; Blok B; de Wachter S; Pezzella A; Gruenenfelder J; Pakzad M; Perrouin-Verbe MA; Van Kerrebroeck P; Mangel J; Peters K; Kennelly M; Shapiro A; Lee U; Comiter C; Mueller M; Goldman H; Lane F
Neurourol Urodyn; 2020 Jun; 39(5):1482-1488. PubMed ID: 32339339
[TBL] [Abstract][Full Text] [Related]
37. SACRAL NEUROMODULATION IN TREATING OVERACTIVE BLADDER PATIENTS - FIRST-TIME APPLICATION IN CROATIA.
Bakula M; Hauptman D; Hudolin T; Škegro SN; Tudor KI; Bakula B; Kaštelan Ž
Acta Clin Croat; 2023 Jul; 62(Suppl2):143-147. PubMed ID: 38966014
[TBL] [Abstract][Full Text] [Related]
38. Sacral neuromodulation for overactive bladder in women: do age and comorbidities make a difference?
High RA; Winkelman W; Panza J; Sanderson DJ; Yuen H; Halder G; Shaver C; Bird ET; Rogers RG; Danford JM
Int Urogynecol J; 2021 Jan; 32(1):149-157. PubMed ID: 32588075
[TBL] [Abstract][Full Text] [Related]
39. Detrusor overactivity does not predict outcome of sacral neuromodulation test stimulation.
South MM; Romero AA; Jamison MG; Webster GD; Amundsen CL
Int Urogynecol J Pelvic Floor Dysfunct; 2007 Dec; 18(12):1395-8. PubMed ID: 17364132
[TBL] [Abstract][Full Text] [Related]
40. Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device.
Zhang Y; Zhang P; Tian X; Chen G; Li Y; Zhang Y; Xu Z; Wei Z; Zhang W; Ma L; Shi B; Liao L; Wang J
World J Urol; 2019 Nov; 37(11):2481-2492. PubMed ID: 30809700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
